Explore

Trendline Trendline
MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million

MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million

MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million
Trendline Trendline
MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals
Trendline Trendline
MacroGenics Sells Maryland Drug Plant to Bora Pharmaceuticals for $122.5 Million

MacroGenics Sells Maryland Drug Plant to Bora Pharmaceuticals for $122.5 Million

MacroGenics Sells Maryland Drug Plant to Bora Pharmaceuticals for $122.5 Million
Trendline Trendline
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
Trendline Trendline
MacroGenics Sells Maryland Drug Plant to Bora for $122.5 Million, Impacting 140 Workers

MacroGenics Sells Maryland Drug Plant to Bora for $122.5 Million, Impacting 140 Workers

MacroGenics Sells Maryland Drug Plant to Bora for $122.5 Million, Impacting 140 Workers
Trendline Trendline
MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
Trendline Trendline
Bora Group Acquires MacroGenics' Maryland Manufacturing Operations for $122.5 Million

Bora Group Acquires MacroGenics' Maryland Manufacturing Operations for $122.5 Million

Bora Group Acquires MacroGenics' Maryland Manufacturing Operations for $122.5 Million
Trendline Trendline
Bora Group to Acquire MacroGenics' Manufacturing Operations for $122.5 Million

Bora Group to Acquire MacroGenics' Manufacturing Operations for $122.5 Million

Bora Group to Acquire MacroGenics' Manufacturing Operations for $122.5 Million
Trendline Trendline
Hain Celestial's Turnaround Strategy Focuses on Innovation and Functional Products

Hain Celestial's Turnaround Strategy Focuses on Innovation and Functional Products

Hain Celestial's Turnaround Strategy Focuses on Innovation and Functional Products
Trendline Trendline
Coya Therapeutics Reports Financial Results and Advances ALS Treatment

Coya Therapeutics Reports Financial Results and Advances ALS Treatment

Coya Therapeutics Reports Financial Results and Advances ALS Treatment
Trendline Trendline
Biopharma's Future in Ireland: Navigating Stability, Regulation, and Talent Amid Global Shifts

Biopharma's Future in Ireland: Navigating Stability, Regulation, and Talent Amid Global Shifts

Biopharma's Future in Ireland: Navigating Stability, Regulation, and Talent Amid Global Shifts
Trendline Trendline
Porsche to Close Three Subsidiaries Amid Declining Sales and Strategic Shift

Porsche to Close Three Subsidiaries Amid Declining Sales and Strategic Shift

Porsche to Close Three Subsidiaries Amid Declining Sales and Strategic Shift